FDA
label_change
· 2022-08-05
FDA Approved: MYFEMBREE — Supplemental Application (Sumitomo Pharma America, Inc)
Summary
FDA approved a supplemental application for MYFEMBREE (relugolix, estradiol hemihydrate, and norethindrone acetate) from Sumitomo Pharma America, updating the p…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MYFEMBREE (RELUGOLIX, ESTRADIOL HEMIHYDRATE, AND NORETHINDRONE ACETATE)